IPVを経験している患者のために、通常どおりの擁護ベースの強化ケア (RISE)
IPVを経験している患者の強みとエンパワーメント(上昇)とアドボカシーベースの強化ケアを通じてIPVから回復する
This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.
Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Katherine M Iverson, PhD
- 電話番号:857-364-2066
- メール:Katherine.Iverson@va.gov
研究連絡先のバックアップ
- 名前:Julianne Brady
- メール:Julianne.Brady@va.gov
研究場所
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02130
- 募集
- VA Boston Healthcare System
-
コンタクト:
- Katherine M Iverson, PhD
-
-
Minnesota
-
Minneapolis、Minnesota、アメリカ、55417
- 募集
- VA Minneapolis Healthcare System
-
コンタクト:
- Princess Ackland, PhD
-
-
Pennsylvania
-
Philadelphia、Pennsylvania、アメリカ、19104
- 募集
- VA Philadelphia Healthcare System
-
コンタクト:
- Melissa Dichter, PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
- report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
- be able to provide informed consent including permission to have intervention sessions recorded
Exclusion Criteria:
- severe cognitive impairment,
- suicide or homicide intent with a specific plan
- untreated or unstable symptoms of mania or psychosis
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)
Participants randomized to the RISE arm will have 1 or more RISE sessions. |
RISE is personalized, trauma-informed, empowerment-oriented and variable-length, consisting of an initial 60-minute session and up to 7 additional 45-minute sessions (1-8 sessions total). |
|
アクティブコンパレータ:Advocacy-based ECAU (Enhanced Care as Usual)
Participants randomized to this arm will have a single Advocacy-based ECAU session |
Advocacy-based ECAU is a single 60-minute trauma-informed counseling intervention that includes supportive education, validating and empathetic statements, safety planning, resource provision and referrals. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Self-efficacy
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Self-efficacy will be assessed with the General Self-Efficacy Scale (GSES), a 10-item instrument with possible responses for each item from 1 to 4 where 1= Not at all true, 2= Hardly true, 3= Moderately true, and 4=Exactly true.Scores can range from 10 to 40 and higher scores indicate more self efficacy. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Depressive symptoms
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Depressive symptoms will be assessed with the Center for Epidemiologic Studies Depression Scale (CESD), a 20-item instrument with possible responses for each item from 0 to 3 where 0= Rarely or none of the time (less than 1 day), 1= Some or a little of the time (1-2 days), 2= Occasionally or a moderate amount of the time (3-4 days), and 3= Most or all of the time (5-7 days). Possible range of scores is 0 to 60, with the higher scores indicating more depressive symptoms. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Post traumatic stress disorder (PTSD) symptoms
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
PTSD symptoms will be assessed with the PTSD Checklist -DSM-5, a 20-item self-report measure of the DSM-5 symptoms of PTSD. A 5-point Likert scale is used for each item from 0 = "Not at all" to 4 = "Extremely". Total possible scores can range from 0 to 80 with higher scores indicating more PTSD symptoms. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Alcohol use
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Alcohol use will be assessed with the Alcohol Use Disorders Identification Test-10 (AUDIT-10), a 10-item instrument with possible responses for each item from 0 to 4 for questions 1-8 and possible responses of 0, 2, and 4 for questions 9 and 10. Total possible scores can range from 0 to 40 with higher scores indicating greater alcohol use. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Hopelessness
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Hopelessness will be assessed by the 20-item Beck Hopelessness Scale (BHS). The BHS is scored by adding up the responses to 20 true-false questions. The possible score range is 0-20, with higher scores indicating greater hopelessness. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Self-reported quality of life
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Quality of life will be assessed by World Health Organization - Quality of Life, Brief WHOQOL-BREF instrument, a 26-item instrument consisting of four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains QOL and general health items. Each individual item of the WHOQOL-BREF is scored from 1 to 5 on a response scale, which is stipulated as a five-point ordinal scale. The scores are then transformed linearly to a 0-100-scale with higher scores indicating a better quality of life. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Valued living
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Valued living will be assessed with the Valued Living Questionnaire (VLQ) focusing on 10 valued domains of living which include (1) family, (2) marriage/couples, intimate relations, (3) parenting, (4) friendship, (5) work, (6) education, (7) recreation, (8) spirituality, (9) citizenship, and (10) physical self-care. Each domain is rated on a scale of 1-10, based on the level of importance to the respondent and the extent to which they have lived consistent with their values in the past week. A total score is calculated by multiplying the importance and consistency ratings for each domain, and then averaging those scores. Total scores range from 10 to 100 with higher scores indicating greater alignment with one's values. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
IPV
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Experiences of IPV from past or a current intimate partner will be measured using subscales of the Revised Conflict Tactics Scale (CTS-2). The physical aggression (12 items), psychological aggression (8 items), and sexual coercion (7 items) subscales include 27 items regarding the frequency of different IPV experiences (0=this has never happened, 1=1 time, 2=2 times, 3=3-5 times, 4=6-10 times, 5=11-20 times, and 6=20+ times). Items are summed for a total frequency score. Additionally, the number of different IPV behaviors experienced can be tallied to reflect a indicate the number of different IPV behaviors experienced. Higher scores reflect greater levels of IPV experience. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Measure of Victim Empowerment Related to Safety
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Safety-related Empowerment will be measured with the Measure of Victim Empowerment Related to Safety (MOVERS), a 13- item measure that consists of three subscales: internal resources (6 items), expectations of support (4 items), and trade-offs (3 items), with response options on a scale from 1-5, with 1 being "never true" and 5 being "always true" for each internal resource and expectation of support subscale question. Responses options for the trade-off subscale are reverse scored with 1 = Always true and 5= Never true. Total possible scores can range from 13 to 65, with higher scores indicating higher levels of empowerment. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
Health care and social service use
時間枠:Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
Items adapted from the National Survey of Veterans and prior studies examining health and social service use among individuals experiencing IPV, particularly in terms of VA and non-VHA psychosocial health services (e.g., mental health, housing, domestic violence agencies). The number and types of psychosocial treatment services will be examined. |
Baseline, 3 months, 6 months. 9 months, 12 months, 15 months
|
|
VHA health care use
時間枠:12 months before baseline, 12 months after baseline
|
VHA health care use will be extracted from the electronic medical records. The types and number of services used, particularly psychosocial health services, will be examined. |
12 months before baseline, 12 months after baseline
|
|
Treatment satisfaction
時間枠:3 months
|
Treatment satisfaction will be assessed using the 8-item Client Satisfaction Questionnaire-8 (CSQ-8). Possible scores range from 8 to 32, with higher values indicating higher treatment satisfaction. |
3 months
|
|
Perceived Benefits/Harms
時間枠:3 months
|
Perceived benefits/harms from participating in the interventions will be measured using 6 items adapted from prior studies. Possible responses on a Likert scale range from 1= strongly disagree to 5 = strongly agree, with item 4 reverse scored. Individual item scores and total scores will be examined. |
3 months
|
協力者と研究者
スポンサー
協力者
捜査官
- 主任研究者:Katherine M Iverson, PhD、V Boston Healthcare System, BU CASchool Medicine Psychiatry
- 主任研究者:Melissa Dichter, PhD MSW、VA Philadelphia Healthcare System
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- H-45215
- BPS-2023C2-33320 (その他の助成金/資金番号:PCORI)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。